Publication Topic

Doepker C, Franzen A, Brorby G, Brown L, Choksi N, East A, Wikoff D. 2026. Smoke flavoring—A case study demonstrating the value of using benefit-risk analysis for foods (BRAFO) to provide transparency for risk management decisions. Regul Toxicol Pharmacol 167(May):106033; doi: 10.1016/j.yrtph.2026.106033. PMID: 41577161.

Allen B, Heitz E, Goodman S, Freedman A, Miller S, Haver C, Snow S, Weinberger K, et al. Understanding the cancer outcomes associated with exposure to jet fuels: A fit-for-purpose systematic literature review. Abstract 4676, Society of Toxicology 64^th Annual Meeting, Orlando, FL, March 2025.

Fender CL, Morshead M, Cohen C, Truong L, Rohlman D, Tanguay R, Jaramillo-Garcia M. Suspects and nontarget chemical analyses to address community concerns related to chemicals and toxicity in the Portland harbor. Poster presentation at SRP Annual Conference, Albuquerque, NM, 2023.

Cohen SS, Bylsma LC, Movva N, Alexander DD. 2022. Theoretical attributable risk analysis and Disability Adjusted Life Years (DALYs) based on increased dairy consumption. BMC Public Health 22(1):1625; doi: 10.1186/s12889-022-14042-7. PMID: 36030208.

Wheeler MW, Cortiñas Abrahantes J, Aerts M, Gift JS, Allen Davis J. 2022. Continuous model averaging for benchmark dose analysis: Averaging over distributional forms. Environmetrics 33(5):e2728; doi: 10.1002/env.2728. PMID: 36589902.

Haber LT, Pecquet AM, Vincent MJ, White LM. 2022. The long goodbye: Finally moving on from the relative potency approach to a mixtures approach for polycyclic aromatic hydrocarbons (PAHs). Int J Env Res Pub Health 19(15):9490; doi: 10.3390/ijerph19159490. PMID: 35954852.

Wheeler MW, Westerhout J, Baumert JL, Remington BC. 2021. Bayesian stacked parametric survival with frailty components and interval‐censored failure times: An application to food allergy risk. Risk Anal 41(1):56-66; doi: 10.1111/risa.13585. PMID: 33063372.

Houben GF, Baumert JL, Blom WM, Kruizinga AG, Meima MY, Remington BC, Wheeler MW, Westerhout J, Taylor SL. 2020. Full range of population eliciting dose values for 14 priority allergenic foods and recommendations for use in risk characterization. Food Chem Toxicol 146(Dec)111831; doi: 10.1016/j.fct.2020.111831. PMID: 33166672.

Pham LL, Borghoff SJ, Thompson CM. 2020. Comparison of threshold of toxicological concern (TTC) values to oral reference dose (RfD) values. Regul Toxicol Pharmacol 113(June):104651; doi: 10.1016/j.yrtph.2020.104651. PMID: 32229245.

Wheeler MW, Piegorsch WW, Bailer AJ. 2019. Quantal risk assessment database: A database for exploring patterns in quantal dose‐response data in risk assessment and its application to develop priors for Bayesian dose‐response analysis. Risk Anal 39(3):616-29; doi: 10.1111/risa.13218. PMID: 30368842.

Wikoff DS, Thompson C, Rager J, Chappell G, Fitch S, Doepker C. 2018. Benefit-risk analysis for foods (BRAFO): Evaluation of exposure to dietary nitrates. Food Chem Toxicol 120(Oct):709-723; doi: 10.1016/j.fct.2018.08.031. PMID: 30134152.

Wheeler MW, Shao K, Bailer AJ. 2015. Quantile benchmark dose estimation for continuous endpoints. Environmetrics 26(5):363-72; doi: 10.1002/env.2432.

Reichert H, Meddings J. What’s so standard about risk standardization? Presented at the 2014 American Statistical Association (ASA) Conference on Statistical Practice, Tampa, FL, February 2014.

James RC, Britt J, Halmes N, Guzelian P. 2014. Comments on recent discussions providing differing causation methodologies. Hum Experim Toxicol 33(1):109-112; doi: 10.1177/0960327113491511. PMID: 23749455.

Wheeler MW, Bailer AJ. 2013. An empirical comparison of low-dose extrapolation from points of departure (PoD) compared to extrapolations based upon methods that account for model uncertainty. Regul Toxicol Pharmacol 67(1):75-82; doi: 10.1016/j.yrtph.2013.06.006. PMCID: PMC4724873

Reichert H. Risk standardization. Presented at the Institute for Healthcare Policy and Innovation (IHPI) Methods Seminar, Ann Arbor, MI, June 2013.

Thomas RS, Rowlands JC, Budinsky RA, Thompson CM, Urban JD, Dombkowski, A. 2011. Genomic approaches for relative potency assessment. Presented at Dioxin 2011, Brussels, Belgium, August 2011.

Alexander DD, Schmitt D, Tran N, Barraj L, Cushing CA. Partially hydrolyzed 100% whey infant formula and atopic dermatitis risk reduction: A systematic review of the literature. Program abstract, Experimental Biology, New Orleans, LA, 2009.

Wheeler MW, Bailer AJ. 2009. Benchmark dose estimation incorporating multiple data sources. Risk Anal 29(2):249-56; doi: 10.1111/j.1539-6924.2008.01144x. PMID: 19000080.

Wheeler MW, Bailer AJ. 2008. Model averaging software for dichotomous dose response risk estimation. J Stat Software 26(5):1-15; doi: 10.18637jss.v026.i05.